Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine

Quarterly-SFG-Jan-to-March
SFG FRC 2026

Source: The post is based on the article “Union Minister launches the GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine” published in PIB on 23rd June 2023

What is the News?

The Union Minister of Science and Technology has launched GEMCOVAC® -OM, an Omicron-specific mRNA-based Booster vaccine.

What is GEMCOVAC-OM?

GEMCOVAC-OM is an indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus.

It is India’s first mRNA vaccine.

Developed by: Pune based Gennova Biopharmaceuticals with funding support from the Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC). 

Features: It is a thermostable vaccine and does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines.

– It is delivered intra-dermally using a needle-free injection device system.

– It will for now only be available as a booster or “precaution dose”.

Print Friendly and PDF
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Blog
Academy
Community